Synjardy — Explained by Medical Evidence, Not Myths

Synjardy is a prescription medicine for adults with type 2 diabetes that combines empagliflozin and metformin in one tablet. Understanding what it does, who it helps, and when it may not be suitable can make treatment safer and more effective.

What Synjardy is and what it is used for

Synjardy is a prescription medicine used to help manage type 2 diabetes in adults. It contains two active ingredients: empagliflozin and metformin. Together, these medicines lower blood glucose in different ways, which can help improve overall diabetes control when combined with healthy eating, physical activity, and regular medical care.

Empagliflozin belongs to a group of medicines called SGLT2 inhibitors. It works by helping the kidneys remove some extra glucose from the body through the urine. Metformin reduces glucose production in the liver and helps the body respond better to insulin. Because the two medicines act differently, combining them may be useful for some people who need more than one approach to control blood sugar.

Synjardy is generally prescribed for people with type 2 diabetes who would benefit from both ingredients in a single medicine. In some patients, a doctor may also consider the broader health benefits associated with empagliflozin, especially when diabetes occurs alongside cardiovascular or kidney concerns. The exact reason for prescribing it depends on the person’s medical history, blood sugar patterns, kidney function, and treatment goals.

It is important to note that Synjardy is not appropriate for everyone with high blood sugar. It is not used to treat type 1 diabetes, and it should not be used to treat diabetic ketoacidosis. A healthcare professional can explain whether this medicine fits into a person’s overall diabetes treatment plan.

How Synjardy works in the body

Understanding Synjardy can be easier when each ingredient is considered separately. Metformin mainly acts in the liver and digestive system. It lowers the amount of glucose released by the liver and improves insulin sensitivity, helping the body use insulin more effectively. This usually lowers blood sugar without directly forcing the pancreas to release more insulin.

Empagliflozin works through the kidneys. Normally, the kidneys filter glucose and then reabsorb most of it back into the bloodstream. Empagliflozin blocks part of this reabsorption, so more glucose leaves the body in urine. As a result, blood glucose levels can decrease.

Because Synjardy uses these two mechanisms together, it may help some patients achieve better control than with one medicine alone. However, response varies from person to person. Blood sugar results also depend on food choices, exercise, sleep, body weight, other illnesses, and whether medicines are taken consistently.

Patients sometimes ask whether Synjardy “cures” diabetes. It does not cure type 2 diabetes. Instead, it helps manage the condition and may lower the risk of some diabetes-related complications when used as part of a broader care plan, including monitoring and lifestyle measures.

Who may benefit from Synjardy and who may not

Synjardy may be considered for adults with type 2 diabetes who need blood sugar lowering from both metformin and empagliflozin. It can be especially practical for people already taking the two medicines separately, because one combination tablet may simplify the daily routine. A simpler regimen can sometimes support more consistent use.

Doctors do not choose this medicine based only on blood glucose numbers. They also consider kidney function, age, hydration status, other medicines, risk of infections, alcohol use, and planned surgeries or scans that involve contrast dye. In some cases, another treatment may be safer or more appropriate.

Synjardy may not be suitable for people with significantly reduced kidney function, certain severe acute illnesses, dehydration, or a history that raises concern for lactic acidosis or ketoacidosis. It is also used cautiously in people who are frail, have recurrent urinary or genital infections, or are at risk of low blood pressure. Pregnancy, breastfeeding, and major changes in health status should always be reviewed with a clinician.

If blood sugar remains difficult to control, doctors may also assess whether other therapies are needed. Depending on the situation, care may include counseling on endocrinology and metabolic diseases treatment and a tailored review of medications, nutrition, activity, and long-term complication risk.

Common side effects and important safety warnings

Many people tolerate Synjardy well, but side effects can happen. The metformin part commonly causes digestive symptoms, especially at the beginning of treatment. These may include nausea, diarrhea, abdominal discomfort, reduced appetite, or a metallic taste. Taking the medicine with food often helps, and some side effects improve as the body adjusts.

The empagliflozin part can increase glucose in the urine, which may raise the chance of genital yeast infections and urinary tract infections in some people. It may also lead to increased urination and fluid loss. For this reason, staying hydrated is important, especially during hot weather, illness, or fasting. Some patients may feel dizzy if blood pressure falls.

There are also uncommon but serious safety concerns. Metformin has a rare risk of lactic acidosis, a medical emergency more likely in settings such as severe kidney impairment, dehydration, severe infection, heavy alcohol use, or low oxygen states. Empagliflozin has been linked to ketoacidosis, which can occasionally occur even when blood sugar is not extremely high. Warning signs can include nausea, vomiting, stomach pain, unusual tiredness, difficulty breathing, or confusion.

Another important warning is to seek medical advice promptly if symptoms of severe infection develop, particularly around the genital area, or if there are signs of worsening kidney problems. Patients should never ignore persistent vomiting, inability to keep fluids down, or symptoms that suggest dehydration. These situations may require the medicine to be paused and reviewed by a doctor.

How to take Synjardy safely

Synjardy should be taken exactly as prescribed. Doctors usually choose the strength based on what a patient is already taking, current blood sugar control, kidney function, and tolerance. Because metformin can irritate the stomach, the medicine is generally taken with meals. Patients should follow the specific instructions on their prescription label rather than changing the dose on their own.

Missing doses from time to time can reduce the medicine’s benefit. If a dose is forgotten, patients should follow the guidance given by their doctor or pharmacist and avoid doubling up unless specifically instructed. Keeping a regular schedule, using a pill box, or setting reminders may help.

Synjardy should be reviewed before surgery, severe illness, dehydration, or imaging procedures that use iodinated contrast. In these situations, a healthcare team may advise temporarily stopping the medicine and restarting it later, once kidney function and hydration are stable. This is a practical safety step and does not necessarily mean the medicine is unsuitable in the long term.

Patients should also tell their doctor about all other medicines they take, including diuretics, insulin, sulfonylureas, steroids, and over-the-counter supplements. Combining diabetes medicines can be appropriate, but it may change the risk of side effects or low blood sugar. A structured follow-up plan, sometimes including regular check-ups, helps treatment stay both safe and effective.

Monitoring, lifestyle, and what treatment success looks like

Synjardy works best as one part of a broader diabetes care strategy. Monitoring usually includes blood glucose checks as recommended by the doctor, periodic HbA1c testing, kidney function tests, and review of symptoms such as recurrent infections or digestive side effects. Some patients may also need blood pressure, weight, and hydration status assessed regularly.

Healthy lifestyle habits remain important even when a person is taking effective medicine. A balanced eating plan, regular physical activity, good sleep, and not smoking can support better glucose control and reduce long-term cardiovascular risk. No medicine can fully replace these foundations of care.

Treatment success is not only about a single lab result. It also means the regimen is realistic, side effects are manageable, and the patient understands when to ask for help. For some people, success includes weight management, fewer blood sugar swings, or better protection of overall health over time.

If diabetes is difficult to manage or complications are a concern, doctors may evaluate for related conditions affecting the kidneys, nerves, eyes, or heart. Broader assessment can be especially useful when there are symptoms suggesting issues beyond glucose levels alone.

Myths and facts about Synjardy

Several common myths can make this medicine seem more confusing than it is. One myth is that Synjardy is simply a stronger form of metformin. In fact, it is a combination medicine with two separate ingredients that work in different ways. Another myth is that if blood sugar improves, the medicine can be stopped without medical advice. Diabetes treatment should only be changed under professional guidance.

Some people worry that passing more glucose in the urine means the kidneys are being harmed. The intended action of empagliflozin is to increase urinary glucose excretion, but kidney function still needs regular monitoring because the medicine is not suitable in all kidney conditions. The effect itself is expected, but safe use depends on the patient’s overall health.

Another misconception is that all side effects mean the medicine has failed. Mild stomach upset or increased urination can happen early and may be manageable, while certain rare symptoms require urgent attention. The key is not to guess, but to review symptoms with a clinician who can decide whether the treatment should continue, be adjusted, or be replaced.

Finally, Synjardy is not a substitute for personalized care. Type 2 diabetes varies widely from one person to another, and treatment may include lifestyle changes, tablets, injectables, or insulin. Clear communication with the healthcare team helps ensure that decisions are based on medical evidence rather than myths.

When to seek medical care

Medical advice should be sought promptly if symptoms suggest dehydration, ketoacidosis, or severe infection. Examples include repeated vomiting, trouble breathing, severe weakness, confusion, intense abdominal pain, very reduced urination, fever, or rapidly worsening redness and pain in the genital area. These are not symptoms to monitor at home for long periods.

Patients should also contact a doctor if they have persistent diarrhea, cannot keep fluids down, develop symptoms of a urinary tract or genital infection, or notice dizziness that does not improve. Blood sugar readings that stay unusually high or low despite taking medicines correctly also deserve review.

Routine care matters too. Regular appointments allow doctors to check HbA1c, kidney function, and how well the treatment fits the patient’s daily life. If needed, assessment may include support for related problems such as obesity or other metabolic conditions that can make diabetes harder to manage.

For international patients who need coordinated evaluation, Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat diabetes and related metabolic conditions. A qualified doctor can decide whether Synjardy is appropriate, whether another option would be safer, or whether further testing is needed.

Frequently asked questions

What is Synjardy used for?

Synjardy is used to help control blood sugar in adults with type 2 diabetes. It combines empagliflozin and metformin, so it is usually prescribed when both types of action are considered helpful as part of an overall diabetes care plan.

Is Synjardy the same as metformin?

No. Synjardy contains metformin, but it also contains empagliflozin. That means it is a combination medicine rather than metformin alone.

Can Synjardy cause low blood sugar?

By itself, Synjardy is less likely to cause low blood sugar than some other diabetes medicines. However, the risk can increase if it is taken with insulin or certain tablets such as sulfonylureas, or if food intake is reduced.

What are the most common side effects of Synjardy?

Common side effects include nausea, diarrhea, stomach discomfort, increased urination, and genital or urinary infections. Many digestive symptoms improve with time or when the medicine is taken with meals, but ongoing or severe symptoms should be discussed with a doctor.

Should Synjardy be stopped before surgery or scans?

Sometimes, yes. Doctors may advise temporarily stopping Synjardy before surgery, severe illness, dehydration, or scans that use iodinated contrast, depending on kidney function and the clinical situation. Patients should always follow the specific advice of their healthcare team.

Is Synjardy safe for people with kidney problems?

It may not be suitable for everyone with kidney disease. Kidney function needs to be checked before and during treatment because both safe use and dosing decisions depend on how well the kidneys are working.

References

• American Diabetes Association
• National Institute of Diabetes and Digestive and Kidney Diseases
• U.S. Food and Drug Administration
• National Health Service
• European Medicines Agency

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.